| Peer-Reviewed

Severity of Anxiety Among Cervical Cancer Patients in Referral Hospitals in Western Kenya

Received: 12 September 2022    Accepted: 27 September 2022    Published: 17 October 2022
Views:       Downloads:
Abstract

Cervical cancer diagnosis may cause patients to experience anxiety since it is a life threatening illness. The treatment of cervical cancer has side effects and complications that may worsen the anxiety experience at different levels. This study sought to determine the severity of anxiety among cervical cancer patients attending referral hospitals in Western Kenya. Data on severity of anxiety was obtained using Becks Anxiety Inventory (BAI), from 218 cervical cancer patients. Data was entered into SPSS version 23 and univariate and bivariate analysis were done. The study found that the participant with moderate symptoms of anxiety were the most at 34.4% as opposed to mild (26.6%) and severe anxiety (19.3%). Participants aged 40-49 years had higher symptoms of moderate anxiety (12.4%), mild anxiety (9.2%) and severe anxiety (8.3%) compared to other age groups. Those who responded to having primary level of education had a higher level of moderate anxiety (19.7%), mild anxiety (13.8%) and severe anxiety (13.3%) compared to participants with other levels of education. Married participants had the highest number of moderate anxiety (20.2%), mild anxiety (20.2%) and severe anxiety (13.8%) compared to participants of other marital status categories. Those who reported to have receive social support from family members had more symptoms of moderate anxiety (20.2%), mild anxiety (14.2%) and severe anxiety (10.1%) as compared to those who responded to not having received any social support and other social support categories. Anxiety was found to be more severe among participants who had a combination treatment of chemotherapy and radiotherapy with moderate anxiety at 16.1%, mild anxiety at 15.1%, and severe anxiety at 11.5% compared to those who had other forms of single treatments. This study concludes that levels of anxiety vary among cervical cancer patients hence the need for routine assessment during care and rehabilitation.

Published in American Journal of Applied Psychology (Volume 11, Issue 5)
DOI 10.11648/j.ajap.20221105.13
Page(s) 142-147
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Anxiety, Severity, Cervical Cancer Patients, Hospital, Kenya

References
[1] Mattsson, E., Einhorn, K., Ljungman, L., Sundström-Poromaa, I., Stålberg, K., & Wikman, A. (2018). Women treated for gynaecological cancer during young adulthood – A mixed-methods study of perceived psychological distress and experiences of support from health care following end-of-treatment. Gynecologic Oncology, 149 (3), 464–469. https://doi.org/10.1016/j.ygyno.2018.03.055
[2] Simard, S., & Savard, J. (2015). Screening and comorbidity of clinical levels of fear of cancer recurrence. Journal of Cancer Survivorship, 9 (3), 481–491. https://doi.org/10.1007/s11764-015-0424-4
[3] Sharpe, L., Curran, L., Butow, P., & Thewes, B. (2018). Fear of cancer recurrence and death anxiety. Psycho-Oncology, 27 (11), 2559–2565. https://doi.org/10.1002/pon.4783
[4] Lagerdahl, A. S. K., Moynihan, M., & Stollery, B. (2014). An exploration of the existential experiences of patients following curative treatment for cancer: Reflections from a U.K. Sample. Journal of Psychosocial Oncology, 32 (5), 555–575. https://doi.org/10.1080/07347332.2014.936647
[5] Fardell, J. E., Thewes, B., Turner, J., Gilchrist, J., Sharpe, L., Smith, A. ‘Ben,’ Girgis, A., & Butow, P. (2016). Fear of cancer recurrence: A theoretical review and novel cognitive processing formulation. Journal of Cancer Survivorship, 10 (4), 663–673. https://doi.org/10.1007/s11764-015-0512-5
[6] Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013). Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors—A systematic review of quantitative studies. Psycho-Oncology, 22 (1), 1–11. https://doi.org/10.1002/pon.3022
[7] Beck, A. T. (1979). Cognitive Therapy of Depression. Guilford Press.
[8] Leung, P. W. L., & Wong, M. M. T. (1998). Can Cognitive Distortions Differentiate between Internalising and Externalising Problems? The Journal of Child Psychology and Psychiatry and Allied Disciplines, 39 (2), 263–269. https://doi.org/10.1017/S0021963097001868
[9] Milligan, F., Martinez, F., Aal, S. H. M. A., Ahmed, S. A., Joby, B., Matalam, J. S., Nair, S. S., De Leon Maxion, A., Sayed, S., & Melepeedikayil, S. S. (2018). Assessing anxiety and depression in cancer patients. British Journal of Nursing, 27 (10), S18–S23. https://doi.org/10.12968/bjon.2018.27.10.S18
[10] Olivia A. Urbaniec MPsych (Clin), MPsych (Clin), K. C., PhD, L. A. D. Mp., & PhD, H. S. W. (2011). Gynecological Cancer Survivors: Assessment of Psychological Distress and Unmet Supportive Care Needs. Journal of Psychosocial Oncology, 29 (5), 534–551. https://doi.org/10.1080/07347332.2011.599829
[11] Zhao, H., Zhao, Z., & Chen, C. (2020). Prevalence, risk factors and prognostic value of anxiety and depression in cervical cancer patients underwent surgery. Translational Cancer Research, 9 (1), 65–74. https://doi.org/10.21037/tcr.2019.11.04
[12] Julian, L. J. (2011). Measures of Anxiety. Arthritis Care & Research, 63 (0 11), 10.1002/acr.20561. https://doi.org/10.1002/acr.20561
[13] Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56 (6), 893–897. https://doi.org/10.1037/0022-006X.56.6.893
[14] Benali, K., Tazi, M. A., Kietga, G., Kebdani, T., Hassouni, K., Majjaoui, S. E., Kacemi, H. E., & Benjaafar, N. (2022a). The Experience of Pain and Anxiety in Cervical Cancer Patients Undergoing Multiple Fraction High-Dose Rate Brachytherapy: A Prospective Observational Study. Journal of Cancer Therapy, 13 (7), 405–416. https://doi.org/10.4236/jct.2022.137035
[15] Mazzocco, K., Masiero, M., Carriero, M. C., & Pravettoni, G. (2019). The role of emotions in cancer patients’ decision-making. Ecancer medical science, 13, 914. https://doi.org/10.3332/ecancer.2019.914
[16] Roy Chowdhury, S., Bohara, A. K., & Drope, J. (2021). Comparison of mental burden across different types of cancer patients in Nepal: A special focus on cervical cancer patients. Journal of Health Research, 36 (5), 889–897. https://doi.org/10.1108/JHR-01-2021-0034
[17] Jyani, G., Chauhan, A. S., Rai, B., Ghoshal, S., Srinivasan, R., & Prinja, S. (2020). Health-related quality of life among cervical cancer patients in India. International Journal of Gynecologic Cancer, 30 (12), 1887–1892. https://doi.org/10.1136/ijgc-2020-001455
[18] Tekalign, T., & Teshome, M. (2022). Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis. PLOS ONE, 17 (4), e0267571. https://doi.org/10.1371/journal.pone.0267571
[19] Lestyani Nasution, C., Afiyanti, Y., & Milanti, A. (2018). The relationship of the preexisting anxiety problem with the demographic profile of cervical cancer patients. Enfermería Clínica, 28, 199–202. https://doi.org/10.1016/S1130-8621(18)30067-6
[20] Behnamfar, F., & Azadehrah, M. (2015). Factors Associated with Delayed Diagnosis of Cervical Cancer in Iran—A Survey in Isfahan City. Asian Pacific Journal of Cancer Prevention, 16 (2), 635–639. https://doi.org/10.7314/APJCP.2015.16.2.635
[21] Wilford, J., Osann, K., Hsieh, S., Monk, B., Nelson, E., & Wenzel, L. (2018). Validation of PROMIS emotional distress short form scales for cervical cancer. Gynecologic Oncology, 151 (1), 111–116. https://doi.org/10.1016/j.ygyno.2018.07.022
[22] Vistad, I., Cvancarova, M., Kristensen, G. B., & Fosså, S. D. (2011). A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer. Journal of Cancer Survivorship, 5 (2), 208–216. https://doi.org/10.1007/s11764-011-0172-z
[23] Yang, Y.-L., Liu, L., Wang, X.-X., Wang, Y., & Wang, L. (2014). Prevalence and Associated Positive Psychological Variables of Depression and Anxiety among Chinese Cervical Cancer Patients: A Cross-Sectional Study. PLoS ONE, 9 (4), e94804. https://doi.org/10.1371/journal.pone.0094804
[24] Tosic Golubovic, S., Binic, I., Krtinic, D., Djordjevic, V., Conic, I., Gugleta, U., Andjelkovic Apostolovic, M., Stanojevic, M., & Kostic, J. (2022). Risk Factors and Predictive Value of Depression and Anxiety in Cervical Cancer Patients. Medicina, 58 (4), 507. https://doi.org/10.3390/medicina58040507
[25] Oppegaard, K., Harris, C. S., Shin, J., Paul, S. M., Cooper, B. A., Levine, J. D., Conley, Y. P., Hammer, M., Cartwright, F., Wright, F., Dunn, L., Kober, K. M., & Miaskowski, C. (2021). Anxiety profiles are associated with stress, resilience and symptom severity in outpatients receiving chemotherapy. Supportive Care in Cancer, 29 (12), 7825–7836. https://doi.org/10.1007/s00520-021-06372-w
[26] Asrin. (2017). ARC Journal of Public Health and Community Medicine, 2 (2), 19–23.
[27] Kosgei, A., Chesumbai, G., Buziba, N., & Atundo, L. (2018). Cervical Cancer Incidence and Trends in Uasin Gishu County, Kenya (2010 to 2014). Journal of Global Oncology, 4 (Supplement 2), 192s–192s. https://doi.org/10.1200/jgo.18.79501
[28] Anisa, F. N., Kabuhung, E. I., & Amia, R. (2017). Family Support Relationship with The Level of Anxiety in Cervical Cancer Patients Ulin Hospitals Banjarmasin. 124–131. https://doi.org/10.2991/smichs-17.2017.16
Cite This Article
  • APA Style

    Milkah Obwenyi Angachi, Lucy Njiru, Muturi Wachira. (2022). Severity of Anxiety Among Cervical Cancer Patients in Referral Hospitals in Western Kenya. American Journal of Applied Psychology, 11(5), 142-147. https://doi.org/10.11648/j.ajap.20221105.13

    Copy | Download

    ACS Style

    Milkah Obwenyi Angachi; Lucy Njiru; Muturi Wachira. Severity of Anxiety Among Cervical Cancer Patients in Referral Hospitals in Western Kenya. Am. J. Appl. Psychol. 2022, 11(5), 142-147. doi: 10.11648/j.ajap.20221105.13

    Copy | Download

    AMA Style

    Milkah Obwenyi Angachi, Lucy Njiru, Muturi Wachira. Severity of Anxiety Among Cervical Cancer Patients in Referral Hospitals in Western Kenya. Am J Appl Psychol. 2022;11(5):142-147. doi: 10.11648/j.ajap.20221105.13

    Copy | Download

  • @article{10.11648/j.ajap.20221105.13,
      author = {Milkah Obwenyi Angachi and Lucy Njiru and Muturi Wachira},
      title = {Severity of Anxiety Among Cervical Cancer Patients in Referral Hospitals in Western Kenya},
      journal = {American Journal of Applied Psychology},
      volume = {11},
      number = {5},
      pages = {142-147},
      doi = {10.11648/j.ajap.20221105.13},
      url = {https://doi.org/10.11648/j.ajap.20221105.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajap.20221105.13},
      abstract = {Cervical cancer diagnosis may cause patients to experience anxiety since it is a life threatening illness. The treatment of cervical cancer has side effects and complications that may worsen the anxiety experience at different levels. This study sought to determine the severity of anxiety among cervical cancer patients attending referral hospitals in Western Kenya. Data on severity of anxiety was obtained using Becks Anxiety Inventory (BAI), from 218 cervical cancer patients. Data was entered into SPSS version 23 and univariate and bivariate analysis were done. The study found that the participant with moderate symptoms of anxiety were the most at 34.4% as opposed to mild (26.6%) and severe anxiety (19.3%). Participants aged 40-49 years had higher symptoms of moderate anxiety (12.4%), mild anxiety (9.2%) and severe anxiety (8.3%) compared to other age groups. Those who responded to having primary level of education had a higher level of moderate anxiety (19.7%), mild anxiety (13.8%) and severe anxiety (13.3%) compared to participants with other levels of education. Married participants had the highest number of moderate anxiety (20.2%), mild anxiety (20.2%) and severe anxiety (13.8%) compared to participants of other marital status categories. Those who reported to have receive social support from family members had more symptoms of moderate anxiety (20.2%), mild anxiety (14.2%) and severe anxiety (10.1%) as compared to those who responded to not having received any social support and other social support categories. Anxiety was found to be more severe among participants who had a combination treatment of chemotherapy and radiotherapy with moderate anxiety at 16.1%, mild anxiety at 15.1%, and severe anxiety at 11.5% compared to those who had other forms of single treatments. This study concludes that levels of anxiety vary among cervical cancer patients hence the need for routine assessment during care and rehabilitation.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Severity of Anxiety Among Cervical Cancer Patients in Referral Hospitals in Western Kenya
    AU  - Milkah Obwenyi Angachi
    AU  - Lucy Njiru
    AU  - Muturi Wachira
    Y1  - 2022/10/17
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ajap.20221105.13
    DO  - 10.11648/j.ajap.20221105.13
    T2  - American Journal of Applied Psychology
    JF  - American Journal of Applied Psychology
    JO  - American Journal of Applied Psychology
    SP  - 142
    EP  - 147
    PB  - Science Publishing Group
    SN  - 2328-5672
    UR  - https://doi.org/10.11648/j.ajap.20221105.13
    AB  - Cervical cancer diagnosis may cause patients to experience anxiety since it is a life threatening illness. The treatment of cervical cancer has side effects and complications that may worsen the anxiety experience at different levels. This study sought to determine the severity of anxiety among cervical cancer patients attending referral hospitals in Western Kenya. Data on severity of anxiety was obtained using Becks Anxiety Inventory (BAI), from 218 cervical cancer patients. Data was entered into SPSS version 23 and univariate and bivariate analysis were done. The study found that the participant with moderate symptoms of anxiety were the most at 34.4% as opposed to mild (26.6%) and severe anxiety (19.3%). Participants aged 40-49 years had higher symptoms of moderate anxiety (12.4%), mild anxiety (9.2%) and severe anxiety (8.3%) compared to other age groups. Those who responded to having primary level of education had a higher level of moderate anxiety (19.7%), mild anxiety (13.8%) and severe anxiety (13.3%) compared to participants with other levels of education. Married participants had the highest number of moderate anxiety (20.2%), mild anxiety (20.2%) and severe anxiety (13.8%) compared to participants of other marital status categories. Those who reported to have receive social support from family members had more symptoms of moderate anxiety (20.2%), mild anxiety (14.2%) and severe anxiety (10.1%) as compared to those who responded to not having received any social support and other social support categories. Anxiety was found to be more severe among participants who had a combination treatment of chemotherapy and radiotherapy with moderate anxiety at 16.1%, mild anxiety at 15.1%, and severe anxiety at 11.5% compared to those who had other forms of single treatments. This study concludes that levels of anxiety vary among cervical cancer patients hence the need for routine assessment during care and rehabilitation.
    VL  - 11
    IS  - 5
    ER  - 

    Copy | Download

Author Information
  • Department of Clinical Medicine, University of Kabianga, Kericho, Kenya

  • Department of Counselling, Amref International University, Nairobi, Kenya

  • Department of Economics, Daystar University, Nairobi, Kenya

  • Sections